doi: 10.1016/S0022-3476(87)80202-0 39 Abu-OsbaYKMallouhAAHannRW
The findings are compelling: Semaglutide demonstrated the greatest average weight reduction (10.98 kg) Liraglutide, topiramate, metformin, and exenatide also produced significant weight loss Importantly, these interventions were not associated with higher study dropout rates, supporting their overall tolerability
The next frontier in metabolic health: Cagrilintide-Semaglutide and the evolving landscape of therapies
Published in the New England Journal of Medicine, this trial enrolled 2,539 adults with obesity or overweight (with at least one weight-related comorbidity) who did not have diabetes
Common side effects are minimal and may include mild nausea, dizziness, or injection site discomfort
If you eat a large, high-fat meal on the day of your injection, that food may still be in your stomach 48 hours later when the medication is at its strongest, leading to significant nausea or bloating